Literature DB >> 11104563

Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer.

D G Allen1, D J White, A M Hutchins, J P Scurry, S N Tabrizi, S M Garland, J E Armes.   

Abstract

Genetic changes orchestrated by human papillomaviruses are the most important known factors in carcinogenesis of the uterine cervix. However, it is clear that additional genetic events are necessary for tumour progression. We have used comparative genomic hybridization to document non-random chromosomal gains and losses within a subset of 37 cervical carcinomas matched for clinical stage Ib, but with different lymph node status. There were significantly more chromosomal changes in the primary tumours when the lymph nodes were positive for metastases. The most frequent copy number alterations were loss of 3p, 11q, 6q and 10q and gain of 3q. The smallest areas of loss and gain on chromosome 3 were 3p14-22 and 3q24-26. The study identifies progressive DNA copy number changes associated with early-stage invasive cervical cancers with and without lymph node metastases, a factor of potential prognostic and therapeutic value. Copyright 2000 Cancer Research Campaign.

Entities:  

Mesh:

Year:  2000        PMID: 11104563      PMCID: PMC2363460          DOI: 10.1054/bjoc.2000.1509

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma.

Authors:  M Kirchhoff; H Rose; B L Petersen; J Maahr; T Gerdes; C Lundsteen; T Bryndorf; N Kryger-Baggesen; L Christensen; S A Engelholm; J Philip
Journal:  Genes Chromosomes Cancer       Date:  1999-02       Impact factor: 5.006

2.  Distinct cytogenetic alterations in squamous intraepithelial lesions of the cervix revealed by laser-assisted microdissection and comparative genomic hybridization.

Authors:  M Aubele; H Zitzelsberger; U Schenck; A Walch; H Höfler; M Werner
Journal:  Cancer       Date:  1998-12-25       Impact factor: 6.860

3.  Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions.

Authors:  K L Liaw; A G Glass; M M Manos; C E Greer; D R Scott; M Sherman; R D Burk; R J Kurman; S Wacholder; B B Rush; D M Cadell; P Lawler; D Tabor; M Schiffman
Journal:  J Natl Cancer Inst       Date:  1999-06-02       Impact factor: 13.506

4.  Evidence for a putative telomerase repressor gene in the 3p14.2-p21.1 region.

Authors:  H Tanaka; M Shimizu; I Horikawa; H Kugoh; J Yokota; J C Barrett; M Oshimura
Journal:  Genes Chromosomes Cancer       Date:  1998-10       Impact factor: 5.006

5.  Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers.

Authors:  R M Resnick; M T Cornelissen; D K Wright; G H Eichinger; H S Fox; J ter Schegget; M M Manos
Journal:  J Natl Cancer Inst       Date:  1990-09-19       Impact factor: 13.506

6.  Prognostic value of genomic alterations in invasive cervical squamous cell carcinoma of clinical stage IB detected by comparative genomic hybridization.

Authors:  A Dellas; J Torhorst; F Jiang; J Proffitt; E Schultheiss; W Holzgreve; G Sauter; M J Mihatsch; H Moch
Journal:  Cancer Res       Date:  1999-07-15       Impact factor: 12.701

7.  Genetic alterations accumulate during cervical tumorigenesis and indicate a common origin for multifocal lesions.

Authors:  A A Larson; S Y Liao; E J Stanbridge; W K Cavenee; G M Hampton
Journal:  Cancer Res       Date:  1997-10-01       Impact factor: 12.701

8.  Stage IB carcinoma of the cervix, the Norwegian Radium hospital. II. Results when pelvic nodes are involved.

Authors:  P W Martimbeau; K E Kjorstad; T Iversen
Journal:  Obstet Gynecol       Date:  1982-08       Impact factor: 7.661

9.  Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA.

Authors:  M Dürst; R T Dzarlieva-Petrusevska; P Boukamp; N E Fusenig; L Gissmann
Journal:  Oncogene       Date:  1987       Impact factor: 9.867

10.  Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.

Authors:  A M Kersemaekers; J Hermans; G J Fleuren; M J van de Vijver
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

View more
  26 in total

1.  Differential deletions of chromosome 3p are associated with the development of uterine cervical carcinoma in Indian patients.

Authors:  S Dasgupta; S B Chakraborty; A Roy; S Roychowdhury; C K Panda
Journal:  Mol Pathol       Date:  2003-10

2.  LCC15-MB cells are MDA-MB-435: a review of misidentified breast and prostate cell lines.

Authors:  Erik W Thompson; Mark Waltham; Susan J Ramus; Anne-Marie Hutchins; Jane E Armes; Ian G Campbell; Elizabeth D Williams; Phillip R Thompson; James M Rae; Michael D Johnson; Robert Clarke
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

3.  Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears.

Authors:  Sonia Andersson; Pavani Sowjanya; Darawalee Wangsa; Anders Hjerpe; Bo Johansson; Gert Auer; Patti E Gravitt; Catharina Larsson; Keng-Ling Wallin; Thomas Ried; Kerstin Heselmeyer-Haddad
Journal:  Am J Pathol       Date:  2009-11       Impact factor: 4.307

4.  Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer.

Authors:  Kerstin Heselmeyer-Haddad; Kathrin Sommerfeld; Nicole M White; Nadia Chaudhri; Larry E Morrison; Nallasivam Palanisamy; Zhen Yuan Wang; Gert Auer; Winfried Steinberg; Thomas Ried
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

5.  Cellular retinol binding protein 1 could be a tumor suppressor gene in cervical cancer.

Authors:  Mónica Mendoza-Rodriguez; Hugo Arreola; Alejandra Valdivia; Raúl Peralta; Humberto Serna; Vanessa Villegas; Pablo Romero; Beatriz Alvarado-Hernández; Lucero Paniagua; Daniel Marrero-Rodríguez; Marco A Meraz; Mauricio Salcedo
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

6.  Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia.

Authors:  Kerstin Heselmeyer-Haddad; Viktor Janz; Philip E Castle; Nadia Chaudhri; Nicole White; Kim Wilber; Larry E Morrison; Gert Auer; Frances H Burroughs; Mark E Sherman; Thomas Ried
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

Review 7.  Advanced molecular cytogenetics in human and mouse.

Authors:  Kathleen Dorritie; Cristina Montagna; Michael J Difilippantonio; Thomas Ried
Journal:  Expert Rev Mol Diagn       Date:  2004-09       Impact factor: 5.225

8.  Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer.

Authors:  Saskia M Wilting; Jillian de Wilde; Chris J L M Meijer; Johannes Berkhof; Yajun Yi; Wessel N van Wieringen; Boudewijn J M Braakhuis; Gerrit A Meijer; Bauke Ylstra; Peter J F Snijders; Renske D M Steenbergen
Journal:  Genes Chromosomes Cancer       Date:  2008-10       Impact factor: 5.006

9.  Fluorescence in situ hybridization markers for prediction of cervical lymph node metastases.

Authors:  Darawalee Wangsa; Kerstin Heselmeyer-Haddad; Patricia Ried; Elina Eriksson; Alejandro A Schäffer; Larry E Morrison; Juhua Luo; Gert Auer; Eva Munck-Wikland; Thomas Ried; Elisabeth Avall Lundqvist
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

10.  Genome-wide screening of DNA copy number alterations in cervical carcinoma patients with CGH+SNP microarrays and HPV-FISH.

Authors:  Petr Kuglik; Jan Smetana; Vladimira Vallova; Lucie Moukova; Katerina Kasikova; Michaela Cvanova; Lucie Brozova
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.